Last reviewed · How we verify
NCT07476690: CP-rESWT-FREQ
Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Palsy
NA trial testing Real radial extracorporeal shock wave therapy (rESWT) in Cerebral Palsy (CP) in 45 participants. Currently enrolling.
1 March 2026
Quick facts
| Lead sponsor | Sisli Hamidiye Etfal Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 15 November 2025 |
| Primary completion | 1 March 2026 |
| Estimated completion | 15 June 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Real radial extracorporeal shock wave therapy (rESWT)
- Sham radial extracorporeal shock wave therapy (rESWT)
- Conventional physical therapy
Conditions studied
- Cerebral Palsy (CP) — all drugs for Cerebral Palsy (CP) →
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Who can join
Adults 6 to 14, any sex, with Cerebral Palsy (CP). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spasticity is a major contributor to functional limitations in children with cerebral palsy. Radial extracorporeal shock wave therapy (rESWT) has emerged as a non-invasive method for reducing spasticity; however, the optimal session frequency remains unclear. This randomized, assessor-blinded, parallel-group controlled trial investigates the effects of different rESWT session frequencies on spasticity, motor function, balance, pain, and muscle properties in children with cerebral palsy. Participants are randomly assigned to three groups receiving sham rESWT, one real rESWT session per week combined with sham, or two real rESWT sessions per week, in addition to routine neurological rehabilitation. Outcomes are assessed using clinical scales and ultrasonography-based measures, including shear wave elastography. The study aims to define the dose-response relationship of rESWT and inform optimal treatment protocols in pediatric neurorehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07476690
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy (CP)
Currently open trials in the same condition.
- NCT07587476 — Constraint-induced Movement Therapy Combined With Functional Electrical Stimulation in Children With Cerebral Palsy · NA · recruiting
- NCT07500896 — Effects of an Intensive Rhythmic Dance Program on Learning Skills in Children With Cerebral Palsy · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07377201 — Childhood Toxin Perception Survey · recruiting
- NCT07311018 — Neuromuscular Electrical Stimulation and Leap Motion-Based Exercises in Cerebral Palsy · NA · recruiting
Other Sisli Hamidiye Etfal Training and Research Hospital trials
Trials by the same sponsor.
- NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
- NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed
- NCT07351942 — Effectiveness of Low-Load Resistance Training With Blood Flow Restriction in Lateral Epicondylitis · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07476690 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07476690.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing